Projects per year
Personal profile
Biography
Prof Hawkes (MBBS Hons, FRACP, DMedSc) is the Clinical Lymphoma Lead and Steering committee member of the national Lymphoma and Related Diseases Registry in School of Public Health & Preventive Medicine at Monash University. She also holds the roles of Chief Clinical Research Officer at the Olivia Newton-John Cancer Research & Wellness Centre and Lead of the Lymphoma service at Austin Health and in Melbourne Australia.
After completing Medical Oncology training in Melbourne, she undertook a fellowship at the Royal Marsden Hospital, UK and doctoral studies at Melbourne University. She is founder and past president of the Australasian Lymphoma Alliance, is global chair of the global Lymphoma and Related Diseases Registry, chaired the Australasian Leukaemia and Lymphoma Trials Group Lymphoma Working Party from 2017-2023, is a member of Scientific and/or Steering Committees for the American Society of Hematology Lymphoid Malignancies, international Women in Lymphoma group, Global Burkitt Lymphoma Network and is associate editor of ejHaem, with prior appointments as an editorial board member for Blood, Blood Advances and American Society of Clinical Oncology education committee (2020-24). Prof Hawkes runs a large research program of investigator-led trials, registry science and translational work exploring immune targets in lymphoma and has over 170 publications. She is an active member of ASCO, ASH and EHA as well as the International TCL Consortium, Hodgkin Lymphoma HOLISTIC consortium, Global LP Hodgkin Lymphoma network (GLOW).
Education/Academic qualification
Lymphoma, DMedSci, Treatment strategies to improve outcomes in aggressive lymphomas, University of Melbourne
… → Jan 2017
Bachelor of Medicine/Bachelor of Surgery, MBBS (Hons), N/A, MONASH UNIVERSITY
1996 → 2001
External positions
Adjunct Professor, University of Melbourne
2025 → …
Chief Professor, Laboratory Head and Clinical Research Officer, Olivia Newton-John Cancer Research Institute (ONJCRI)
2017 → …
Medical Oncologist, Lymphoma Lead, Austin Health
Oct 2013 → …
Medical Oncologist, Lymphoma Lead, Eastern Health
2013 → 2022
Research area keywords
- Lymphoma
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
-
SDG 5 Gender Equality
Collaborations and top research areas from the last five years
-
Employing radiotherapy to augment glofitamab bispecific antibody immune response in relapsed lymphoma
Hawkes, E. (Primary Chief Investigator (PCI)), Gregory, G. (Chief Investigator (CI)), Lee, D. (Chief Investigator (CI)), Cortissos, P. (Chief Investigator (CI)), McQuilten, Z. (Chief Investigator (CI)), Manos, K. (Chief Investigator (CI)), Barraclough, A. (Chief Investigator (CI)), Scott, A. M. (Chief Investigator (CI)), Campbell, B. A. (Chief Investigator (CI)), Keane, C. (Chief Investigator (CI)), Wight, J. (Chief Investigator (CI)), Khor, R. (Chief Investigator (CI)), Lee, S. T. (Chief Investigator (CI)), Irving, A. (Chief Investigator (CI)) & Rutherford, C. (Chief Investigator (CI))
1/03/26 → 29/02/32
Project: Research
-
Epidemiological Modelling of Australian Patients with Lymphoma
Irving, A. (Primary Chief Investigator (PCI)), Petrie, D. (Supervisor), McQuilten, Z. (Supervisor), Hawkes, E. (Supervisor), Wood, E. (Supervisor), Opat, S. (Supervisor), Barraclough, A. (Supervisor) & Williams, J. (Supervisor)
1/01/26 → 31/12/29
Project: Research
File -
A Centre of Research Excellence in Supportive Care for People with Blood Cancers
McQuilten, Z. (Primary Chief Investigator (PCI)), Wood, E. (Chief Investigator (CI)), Rickard, C. (Chief Investigator (CI)), Agar, M. R. (Chief Investigator (CI)), Hawkes, E. (Chief Investigator (CI)), Henden, A. (Chief Investigator (CI)), Roberts, J. A. (Chief Investigator (CI)), Petrie, D. (Chief Investigator (CI)), Rutherford, C. (Chief Investigator (CI)) & Le, T. (Chief Investigator (CI))
1/11/25 → 31/10/30
Project: Research
-
OPTIMISING NOVEL THERAPIES TO IMPROVE LYMPHOMA PATIENT OUTCOMES
Hawkes, E. (Primary Chief Investigator (PCI))
1/01/23 → 31/12/27
Project: Research
-
VALUE-Ig : eVidence synthesis to inform the optimAL UsE of Immunoglobulin
Petrie, D. (Primary Chief Investigator (PCI)), McQuilten, Z. (Chief Investigator (CI)), Harris, A. (Chief Investigator (CI)), Wood, E. (Chief Investigator (CI)), Irving, A. (Chief Investigator (CI)), Van Der Walt, A. (Chief Investigator (CI)), Reddel, S. W. (Chief Investigator (CI)), Fanning, L. (Chief Investigator (CI)), Spencer, A. (Chief Investigator (CI)), Hawkes, E. (Chief Investigator (CI)) & Crispin, P. (Chief Investigator (CI))
1/04/22 → 31/03/27
Project: Research
-
Toxicity outcomes in phase 1 lymphoma trials abstracts are under-reported, with high use of minimizing language
Maclean, M., Waters, N., Swan, D., Martynchyk, A., Smith, C., Vickers, D., Lee, D., Chong, G. & Hawkes, E. A., Apr 2026, In: HemaSphere. 10, 4, 4 p., e70351.Research output: Contribution to journal › Letter › Research › peer-review
Open Access -
Burkitt lymphoma: click here to add to CAR-T?
Hawkes, E. A. & Gregory, G. P., 5 Jun 2025, In: Blood. 145, 23, p. 2678-2680 3 p.Research output: Contribution to journal › Editorial › Other › peer-review
2 Link opens in a new tab Citations (Scopus) -
Characteristics of Australian and New Zealand patients with chronic lymphocytic leukaemia: a lymphoma and related diseases registry report
Martynchyk, A., Wellard, C., Chung, E., Bhopal, S. K., McQuilten, Z. K., Mulligan, S. P., Opat, S., Wood, E. M., Hawkes, E. A. & Anderson, M. A., Jun 2025, In: Internal Medicine Journal. 55, 6, p. 937-943 7 p.Research output: Contribution to journal › Article › Research › peer-review
1 Link opens in a new tab Citation (Scopus) -
Emerging biomarkers for CD3×CD20 bispecific antibodies in lymphoma
Lewis, C. S., Barraclough, A. & Hawkes, E. A., Apr 2025, In: Blood. 145, 17, p. 1850-1857 8 p.Research output: Contribution to journal › Article › Other › peer-review
4 Link opens in a new tab Citations (Scopus) -
Opportunistic bone density assessment using pretreatment [18F]FDG-PET/CT identifies fracture risk in lymphoma patients undergoing corticosteroid-containing chemotherapy
Douglas, G., Nicholls, K. M., Paul, E., Loh, Z., Lee, S. T., Hackman, K. L., Chiang, C., Waters, N., Chong, G., Prabahran, A. & Hawkes, E. A., Jun 2025, In: Haematologica. 110, 6, p. 1407-1411 5 p.Research output: Contribution to journal › Letter › Research › peer-review
Open Access1 Link opens in a new tab Citation (Scopus)
Prizes
-
Victorian Comprehensive Cancer Centre Tony Burgess Medal
Hawkes, E. (Recipient), Nov 2024
Prize: Prize (including medals and awards)